共 16 条
[1]
Bender B.C., 2013, BR J CLIN PHARM
[3]
Bruno R, 2011, BLOOD, V118, P1881
[4]
Claret L, 2006, J CLIN ONCOL, V24, p307S
[8]
Ichinose Y, 2012, J CLIN ONCOL, V30
[9]
Design of phase II cancer trials using a continuous endpoint of change in tumor size: Application to a study of sorafenib and erlotinib in non-small-cell lung cancer
[J].
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE,
2007, 99 (19)
:1455-1461
[10]
LAVIN PT, 1981, CANCER CLIN TRIALS, V4, P451